GE HealthCare Technologies Inc.
MX ˙ BMV ˙ US36266G1076
SecurityMX:GEHC / GE HealthCare Technologies Inc.
InstitutionJohn G Ullman & Associates Inc
Latest Disclosed Ownership45,210 shares
Latest Disclosed Value $ 3,218,048
John G Ullman & Associates Inc reports 5.34% decrease in ownership of GEHC / GE HealthCare Technologies Inc.

On May 6, 2026 - John G Ullman & Associates Inc filed a 13F-HR form disclosing ownership of 45,210 shares of GE HealthCare Technologies Inc. (MX:GEHC) valued at $3,218,048 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 47,759 shares of GE HealthCare Technologies Inc.. This represents a change in shares of -5.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F GE HEALTHCARE TECHNOLOGI COM 36266G107 45,210 -2,549 -5.34 3,218 -17.85 0.4266
2026-02-05 2025-12-31 13F GE HEALTHCARE TECHNOLOGI COM 36266G107 47,759 -311 -0.65 3,917 8.50 0.5223
2025-11-05 2025-09-30 13F GE HEALTHCARE TECHNOLOGI COM 36266G107 48,070 -3,717 -7.18 3,610 -5.87 0.4861
2025-07-29 2025-06-30 13F GE HEALTHCARE TECHNOLOGI COM 36266G107 51,787 -2,607 -4.79 3,836 -12.64 0.5693
2025-05-06 2025-03-31 13F GE HEALTHCARE TECHNOLOGI COM 36266G107 54,394 -649 -1.18 4,390 2.02 0.6771
2025-02-05 2024-12-31 13F GE HEALTHCARE TECHNOLOGI COM 36266G107 55,043 -438 -0.79 4,303 -17.35 0.6332
2024-11-08 2024-09-30 13F GE HEALTHCARE TECHNOLOGI COM 36266G107 55,481 -1,211 -2.14 5,207 17.86 0.7486
2024-08-08 2024-06-30 13F GE HEATHCARE TECHNOLOGY COM 36266G107 56,692 -381 -0.67 4,417 -14.86 0.6739
2024-05-06 2024-03-31 13F GE HEATHCARE TECHNOLOGY COM 36266G107 57,073 -843 -1.46 5,189 15.86 0.7960
2024-01-31 2023-12-31 13F GE HEATHCARE TECHNOLOGY COM 36266G107 57,916 27,931 93.15 4,478 119.51 0.7103
2023-11-01 2023-09-30 13F GE HEATHCARE TECHNOLOGY COM 36266G107 29,985 22,420 296.36 2,040 232.25 0.3337
2023-08-21 2023-06-30 13F GE HEATHCARE TECHNOLOGY COM 36266G107 7,565 -851 -10.11 615 0.0948
2023-05-05 2023-03-31 13F GE HEATHCARE TECHNOLOGY COM 36266G107 8,416 8,416 1 0.1073
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.